Late Breaking Abstract - Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease - COPD-ST2OP: a phase IIa, placebo-controlled trial

EUROPEAN RESPIRATORY JOURNAL(2021)

引用 1|浏览17
暂无评分
关键词
COPD, Pharmacology, Exacerbation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要